Could a 5-Day radiation blast ease suffering in kids with incurable brain cancer?
NCT ID NCT07147179
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot trial is testing a shorter, 5-day course of radiation for children and young adults (up to age 21) with incurable central nervous system cancers. The main goal is to see if this approach is safe and does not cause severe side effects. Researchers will also track quality of life. Only 15 participants will be enrolled, making this an early safety study.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Radiation therapy (short course, 20 Gray in 5 fractions)
- What this could lead to
- If successful, this could offer a quicker, less burdensome radiation option for children with incurable brain or spinal cancers, potentially improving their quality of life.
- What could go wrong
- This is a very small pilot study (15 participants) with no control group, so results may not apply broadly. The main risk is that the shorter radiation course could cause serious side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL NERVOUS SYSTEM CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.